Bafna
Chennai, India· Est.
Indian CMO delivering EU‑GMP‑certified solid oral dosage forms for global pharma markets.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
Indian CMO delivering EU‑GMP‑certified solid oral dosage forms for global pharma markets.
Technology Platform
Advanced solid oral dosage form manufacturing using EU‑GMP, UK‑MHRA, and TGA‑accredited processes such as wet granulation, dry granulation, direct compression, and film coating.
Opportunities
Rising global demand for outsourced formulation and manufacturing services, especially for small‑molecule oral products, offers Bafna avenues to expand its client base and enter higher‑value markets.
Risk Factors
Regulatory compliance pressures, intense competition from larger CMOs, and the need for continual technology upgrades to handle more complex dosage forms.
Competitive Landscape
Competes with Indian CMOs such as Jubilant Biosys, Piramal Pharma Solutions, and Sun Pharma's contract division; differentiation hinges on multi‑region regulatory accreditations and specialized expertise in solid oral dosage forms.